| LY6E impairs coronavirus fusion and confers immune control of viral disease S Pfaender, KB Mar, E Michailidis, A Kratzel, IN Boys, P V’kovski, W Fan, ... Nature microbiology 5 (11), 1330-1339, 2020 | 198 | 2020 |
| A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication RB Richardson, MB Ohlson, JL Eitson, A Kumar, MB McDougal, IN Boys, ... Nature microbiology 3 (11), 1214-1223, 2018 | 149 | 2018 |
| LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step KB Mar, NR Rinkenberger, IN Boys, JL Eitson, MB McDougal, ... Nature communications 9 (1), 1-14, 2018 | 107 | 2018 |
| Loss of a conserved MAPK causes catastrophic failure in assembly of a specialized cilium-like structure in Toxoplasma gondii WJ O’Shaughnessy, X Hu, T Beraki, M McDougal, ML Reese Molecular biology of the cell 31 (9), 881-888, 2020 | 39 | 2020 |
| Evolution of the interferon response: lessons from ISGs of diverse mammals MB McDougal, IN Boys, P De La Cruz-Rivera, JW Schoggins Current Opinion in Virology 53, 101202, 2022 | 17 | 2022 |
| Interferon inhibits a model RNA virus via a limited set of inducible effector genes MB McDougal, AM De Maria, MB Ohlson, A Kumar, C Xing, JW Schoggins EMBO reports, e56901, 2023 | 7 | 2023 |
| FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms MS Ahmed, AB Farag, IN Boys, P Wang, I Menendez-Montes, ... Biomedicine & Pharmacotherapy 162, 114614, 2023 | 6 | 2023 |
| Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity W Fan, MB McDougal, JW Schoggins Journal of Virology, e01332-22, 2022 | 3 | 2022 |
